JPRN-jRCT2080220761未知3 期
An open-label study of intravenous (i.v.) S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer pain
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Inpatients with pain associated with various cancers
排除标准
- 未提供
研究者
相似试验
未知
3 期
An open-label study of subcutaneous injection (s.c.) S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer paiJPRN-jRCT2080220763SHIONOGI & CO., LTD.
已完成
1 期
A Study of Intravenous Tamiflu (Oseltamivir) in Children With InfluenzaInfluenzaNCT01033734Hoffmann-La Roche8
已完成
1 期
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and NeutropeniaAcute Myeloid LeukemiaNCT03333005Basilea Pharmaceutica20
已完成
不适用
Phase 1, open label study of intravenous GSK3745417 to evaluate safety, tolerability, harmacokinetics, pharmacodynamics and determine RP2D and schedule in participants with relapsed or refractory myeloid malignancies including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS)Cancer of the blood and bone marrowAcute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS)10024324NL-OMON51352GlaxoSmithKline3
撤回
1 期
Safety, Tolerability, and Pharmacokinetics of Sulopenem in AdolescentsUrinary Tract InfectionsPyelonephritis AcuteIntraabdominal InfectionsNCT04700787Iterum Therapeutics, International Limited